Pheochromocytoma: Time to stamp out "malignancy"?

Endocrine Pathology

Volumn 19, Issue 4, 2008, Pages 207-208

  Tischler, Arthur S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE;

ADRENAL GLAND; ADRENAL TUMOR; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CHEMODECTOMA; EDITORIAL; FOLLICULAR CARCINOMA; GENE EXPRESSION; GENETIC DISORDER; MEDICAL SPECIALIST; MELANOMA; METASTASIS; MUTATION; PATHOLOGIST; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; THYROID CARCINOMA; CLASSIFICATION; HUMAN; PATHOLOGY; WORLD HEALTH ORGANIZATION;

ADRENAL GLAND NEOPLASMS; HUMANS; PHEOCHROMOCYTOMA; WORLD HEALTH ORGANIZATION;

EID: 60749097538     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-008-9047-x     Document Type: Editorial

References (4)

1. G Eisenhofer SR Bornstein FM Brouwers 2004 Malignant pheochromocytoma: current status and initiatives for future progress Endocr Relat Cancer 11 423 36
2. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Tumours of endocrine organs. In World Health Organization Classification of Tumors. Lyon: IARC, 2004.
3. Lack EE. Tumors of the adrenal gland and extraadrenal paraganglia. Washington, DC: American Registry Of Pathology, 2007.
4. RE Goldstein JA O'Neill Jr. GW Holcomb 3rd 1999 Clinical experience over 48 years with pheochromocytoma Ann Surg 229 755 64